Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 49 (RPL7AP49) is a human processed pseudogene derived from the gene encoding ribosomal protein L7a, a component of the 60S ribosomal subunit[2][6]. Unlike its parent gene, RPL7A, which is involved in protein synthesis and regulation of nuclear hormone receptors, pseudogenes such as RPL7AP49 do not encode functional proteins and generally have no direct biological or pathological role. Multiple such pseudogene copies exist in the genome as evolutionary remnants of gene duplication or retrotransposition events[2][6]. RPL7AP49 is cataloged in genetic databases for reference purposes but is not considered a candidate for drug targeting or disease association. If you are seeking information about a *functional* ribosomal protein L7a (RPL7A), that is a component of the ribosome involved in protein synthesis, but RPL7AP49 itself is not a protein-coding gene and not a drug target[3][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 49 (RPL7AP49).